Improving Bladder Function in SCI by Neuromodulation
1 other identifier
interventional
24
1 country
1
Brief Summary
This trial will investigate the safety and utility of spinal cord neuromodulation to improve urinary bladder function in the context of spinal cord injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 3, 2015
CompletedFirst Posted
Study publicly available on registry
January 6, 2015
CompletedStudy Start
First participant enrolled
September 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2027
February 13, 2026
February 1, 2026
11.3 years
January 3, 2015
February 10, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Urine flow and volume
Months 1-48
Study Arms (3)
Stimulation of Non-Naive
EXPERIMENTALEvaluate neuromodulation in 6 subjects with prior motor training.
Stimulation of Naive
EXPERIMENTALEvaluate neuromodulation in 6 naive subjects.
Stimulation
EXPERIMENTALApply parameters discovered in Arm 1 and Arm 2 to evaluate neuromodulation in 12 naive subjects.
Interventions
Electromagnetic stimulation to neuromodulate the spinal cord in the context of spinal cord injury.
Eligibility Criteria
You may qualify if:
- Male 18-45 years;
- At least 1 year post-injury;
- Non-progressive SCI at C2-T8 (non-conus injury);
- Motor Complete ASIA (A or B);
- Neurogenic bladder requiring clean intermittent straight catheterization;
- Able to attend twice weekly testing sessions for 6 months.
- Have intact lower extremity anatomy and able to use lower extremity for assistive standing and stepping.
You may not qualify if:
- History of autonomic dysreflexia;
- Ventilator dependency;
- Musculoskeletal dysfunction, unhealed fracture, pressure ulcer, active infection;
- Clinically significant depression or ongoing drug abuse;
- Received botox injection, or bladder surgery (suprapubic access, Brindley procedure, etc.); 6. Prostatic hypertrophy or bladder outlet disorder;
- \. Cardiopulmonary disease that precludes lower extremity training or rehabilitation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, Los Angeles
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 3, 2015
First Posted
January 6, 2015
Study Start
September 1, 2015
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
January 31, 2027
Last Updated
February 13, 2026
Record last verified: 2026-02